(Bloomberg) -- Cantor Fitzgerald LP properly denied $9 million to a half-dozen former partners under non-compete agreements, the Delaware Supreme Court ruled in a decision likely to upend several ...

We noticed you're using an ad blocker. We get it: you like to have control of your own internet experience. But advertising revenue helps support our journalism. To read our full stories, please ...

(Bloomberg) -- Cantor Fitzgerald LP agreed to pay $6.75 million to settle US Securities and Exchange allegations that it misled investors in two blank-check firms before their stock-market debuts.

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

Brandon Lutnick, a trader at his father’s Cantor Fitzgerald LP, has been listed as CEO at its most recently created SPAC, Cantor Equity Partners I Inc., according to a filing Wednesday.

Cantor Fitzgerald initiated coverage of Zoom Communications (ZM) with a Neutral rating and $87 price target Stay Ahead of the Market:Discover ...

Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for PTC Therapeutics in a report ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...

Weakness in Cantor Fitzgerald High Income A's Process and People Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative. Our research team assigns Negative ratings to ...

(Bloomberg) -- Cantor Fitzgerald LP agreed to pay $6.75 million to settle US Securities and Exchange allegations that it misled investors in two blank-check firms before their stock-market debuts. The ...